Results 51 to 60 of about 2,312,065 (203)

Temperature sensitivity of the pyloric neuromuscular system and its modulation by dopamine [PDF]

, 2013
We report here the effects of temperature on the p1 neuromuscular system of the stomatogastric system of the lobster (Panulirus interruptus). Muscle force generation, in response to both the spontaneously rhythmic in vitro pyloric network neural activity
Kevin H. Hobbs, Burstein, Helaine J., Hooper, Scott L., Jeffrey B Thuma, Kevin H Hobbs, Seiter, Natasha S., Scott L. Hooper, Hobbs, Kevin H., Natasha S. Seiter, Scott L Hooper, Natasha S Seiter, Jeffrey B. Thuma, Helaine J. Burstein, Thuma, Jeffrey B., Helaine J Burstein   +14 more
core   +2 more sources

Patient-reported outcome measures in neuromuscular diseases : a scoping review [PDF]

Patient-reported outcome measures (PROMs) are valuable in comprehensively understanding patients' health experiences and informing healthcare decisions in research and clinical care without clinicians' input.
Sistiaga, Andone, Muslemani, Samar, Gagnon, Cynthia, Voet, Nicole, Graham, Christopher, Zaldua, Joana Garmendia, Pater, Ronne, Labayru, Garazi, Gallais, Benjamin, de Groot, Ingrid   +9 more
core   +2 more sources

Digital Monitoring of Patients with Generalized Myasthenia Gravis: A Prospective Pilot Study

Neurology and Therapy
Introduction Monitoring patients with myasthenia gravis (MG) can be challenging due to the fluctuating nature of the disease. We aimed to test the reliability of using the MG Activities of Daily Living (MG-ADL) scale in the form of a smartphone ...
Ana Vesperinas, Josep Rocaspana-Codana, David Reyes-Leiva, Marta Caballero-Ávila, Álvaro Carbayo, Roger Collet-Vidiella, Laura Llansó, Eduard Gallardo, Joana Turon-Sans, Ricard Rojas-García, Elena Cortés-Vicente   +10 more
doaj   +1 more source

Belgian neuromuscular diseases registry, information brochure for patients, 2020

, 2020
Neuromuscular diseases are rare diseases but are affecting more than 250 000 people in Europe. Together we can make a difference. Join us!
M. Jagut, M. Cosyns
core  

Skeletal Muscle MicroRNAs: Their Diagnostic and Therapeutic Potential in Human Muscle Diseases [PDF]

, 2016
MicroRNAs (miRNAs) are small 21–24 nucleotide RNAs that are capable of regulating multiple signaling pathways across multiple tissues. MicroRNAs are dynamically regulated and change in expression levels during periods of early development, tissue ...
Alexander, Matthew S., Kunkel, Louis
core   +1 more source

E-Health Innovation to Overcome Barriers in Neuromuscular Diseases. Report from the 1st eNMD Congress: Nice, France, March 22-23, 2019

, 2021
By definition, neuromuscular diseases are rare and fluctuating in terms of symptoms; patients are often lately diagnosed, do not have enough information to understand their condition and be proactive in their management.
Selb J., Diaz-Manera J., Siciliano G., Hogrel J. -Y., Cavalli C., Puma A., Schirinzi E., Hernando I., Olmedo J. J. S., Lahaut P., Vincent-Genod D., Villa L., Vicart S., Braun S., Pini J., Segovia-Kueny S., Kole A., Vissing J., Vuillerot C., Andr E., Duong T., Bannwarth S., Eggenspieler D., Lochmuller H., Servais L., Sacconi S.   +25 more
core   +1 more source

Factors Associated with the Severity of COVID-19 Outcomes in People with Neuromuscular Diseases: Data from the International Neuromuscular COVID-19 Registry [PDF]

, 2022
Background and purpose: Clinical outcome information on patients with neuromuscular diseases (NMDs) who have been infected with SARS-CoV-2 is limited.
Servidei, Serenella, Ernestina Santos, Oliveira, Acary S B, Serenella Servidei, Lucia Galan, Brady, Stefen, Chiara Pizzamiglio, Pitceathly, Robert DS, Alejandro Horga, Neuromuscular Dis COVID-19 Study G, Galan, Lucia, Hanna, Michael G, Paulo V. Sgobbi Souza, Vishnu Venugopalan, Guido Primiano, Souza, Paulo V. Sgobbi, Robert D. S. Pitceathly, Lunn, Michael P, Wladimir B. V. R. Pinto, Hanna, Michael G., Oliveira, Acary SB, Pedro M. Machado, Pinto, Wladimir B. V. R., Pinto, Wladimir BVR, De Marchi, Fabiola, Pitceathly, Robert D. S., Vishnu, Venugopalan, Heckmann, Jeannine M., Neuromuscular Diseases and COVID-19, Study Group, Benedikt Schoser, Santos, Ernestina, Michael G. Hanna, Oliveira, Acary S. B., Sgobbi Souza, Paulo V, Schoser, Benedikt, for the Neuromuscular Diseases and COVID-19 Study Group, Pizzamiglio, Chiara, Horga, Alejandro, Dimachkie, Mazen M, Michael P. Lunn, Venugopalan, Vishnu, Acary S. B. Oliveira, Neuromuscular Diseases and COVID-19 Study Group, Primiano, Guido, Stefen Brady, Machado, Pedro M., Fabiola De Marchi, Pitceathly, Robert D S, Mazen M. Dimachkie, Maria J. Molnar, Lunn, Michael P., Jeannine M. Heckmann, Molnar, Maria J, Pinto, Wladimir B V R, Machado, Pedro M, Dimachkie, Mazen M., Heckmann, Jeannine M, Mancuso, Michelangelo, Molnar, Maria J.   +58 more
core   +1 more source

Cardiomyopathies and Arrythmias in Neuromuscular Diseases

Neuromuscular diseases (NMDs) encompass various hereditary conditions affecting motor neurons, the neuromuscular junction, and skeletal muscles. These disorders are characterized by progressive muscle weakness and can manifest at different stages of life,
Raimondo Calvanese, Giuseppe Sgarito, Giosuè Mascioli, Carlo Pignalberi, Massimo Zecchin, Calogero Volpe, Martina Nesti, Stefano Bardari, Paolo China, Manlio Cipriani   +9 more
core   +1 more source

Genetic dissection of down syndrome-associated alterations in APP/amyloid-β biology using mouse models

Scientific Reports, 2021
Individuals who have Down syndrome (caused by trisomy of chromosome 21), have a greatly elevated risk of early-onset Alzheimer’s disease, in which amyloid-β accumulates in the brain. Amyloid-β is a product of the chromosome 21 gene APP (amyloid precursor
Justin L. Tosh, Elena R. Rhymes, Paige Mumford, Heather T. Whittaker, Laura J. Pulford, Sue J. Noy, Karen Cleverley, LonDownS Consortium, Matthew C. Walker, Victor L. J. Tybulewicz, Rob C. Wykes, Elizabeth M. C. Fisher, Frances K. Wiseman   +12 more
doaj   +1 more source

Cognition in neuromuscular disease

Journal of Pediatric Rehabilitation Medicine, 2008
Although neuromuscular diseases primarily affect an individual's physical functioning, the cognitive and psychosocial effects of these conditions can be quite significant. This paper provides an overview of a subset of neuromuscular diseases and their associated neurocognitive risks.
Angela Giacoletti, Argento, Jacqueline, Kaufman   +1 more
openaire   +2 more sources